DEWPOINTX Trademark

Trademark Overview

On Wednesday, November 25, 2020, a trademark application was filed for DEWPOINTX with the United States Patent and Trademark Office. The USPTO has given the DEWPOINTX trademark a serial number of 90342769. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 27, 2023. This trademark is owned by Dewpoint Therapeutics, Inc.. The DEWPOINTX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and therapeutic agents for use in wound healing, for use in the treatment of women's health conditions in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), and for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases; reagents for medical use
dewpointx

General Information

Serial Number90342769
Word MarkDEWPOINTX
Filing DateWednesday, November 25, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 29, 2021

Trademark Statements

Description of MarkThe mark consists of the word "DEWPOINTX" in lowercase letters, with the "X" as subscript.
Goods and ServicesPharmaceutical preparations and therapeutic agents for use in wound healing, for use in the treatment of women's health conditions in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), and for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases; reagents for medical use
Pseudo MarkDEW POINT X

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDewpoint Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameDewpoint Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, March 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 12, 2022SOU EXTENSION 2 GRANTED
Friday, August 12, 2022SOU EXTENSION 2 FILED
Friday, August 12, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 15, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 15, 2022SOU EXTENSION 1 FILED
Tuesday, February 15, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 24, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 29, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 9, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 19, 2021NON-FINAL ACTION E-MAILED
Wednesday, May 19, 2021NON-FINAL ACTION WRITTEN
Tuesday, May 11, 2021ASSIGNED TO EXAMINER
Tuesday, February 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 28, 2020NEW APPLICATION ENTERED

Related Keywords

dewpointx diseases disease treatment inflammation infectious auto cancer metabolic prion immune